checkAd
    Startseite > Aktien > Atea Pharmaceuticals > Nachrichten
    Atea Pharmaceuticals Aktie
    3,9600
     
    USD
    +3,39 %
    +0,1300 USD
    Letzter Kurs 04.05.24 Nasdaq
    3,9400
     
    USD
    300 STK
    Geldkurs 03.05.24
    3,9500
     
    USD
    2.800 STK
    Briefkurs 03.05.24
    ISIN: US04683R1068 · WKN: A2QGE7 · SYM: AVIR · USA

    Neueste Nachrichten

    Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
    29.04.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
    27.03.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    28.02.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
    21.02.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19
    08.01.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
    13.11.23 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Announces Participation at Upcoming Investor Conferences
    08.11.23 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
    02.11.23 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call on November 8, 2023
    01.11.23 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
    06.09.23 · globenewswire · Atea Pharmaceuticals
    Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
    08.08.23 · globenewswire · Atea Pharmaceuticals